STA PHARMACEUTICAL HONG KONG INVESTMENT LIMITED
Private company limited by shares (Ltd) · KOWLOON, Hong Kong · LEI 213800N7HZJ1E5B4UP89
LEI lapsed
Summary
STA PHARMACEUTICAL HONG KONG INVESTMENT LIMITED is registered in Hong Kong and entered in the “Companies Registry” under number 72438265. Its legal form is Private company limited by shares (Ltd). According to GLEIF, its ultimate parent is 无锡药明康德新药开发股份有限公司 (China). That group has 2 subsidiaries with LEIs in 2 countries, 2 of them in Hong Kong. The LEI was first issued on 10 Oct 2024 and the record was last updated on 11 Oct 2025. It has lapsed: renewal was due by 10 Oct 2025. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 10 Oct 2025 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2023, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 11 Oct 2025.
Company details
| Legal form | Private company limited by shares (Ltd) |
|---|---|
| Register | Companies Registry · Register website |
| Registration number | 72438265 |
| Jurisdiction | Hong Kong |
| Registered address | UNIT 826, 8/F, OCEAN CENTRE, HARBOUR CITY, 55 CANTON ROAD, TSIM SHA TSUI, KOWLOON, Hong Kong |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 30 Nov 2020 |
| LEI | 213800N7HZJ1E5B4UP89 |
| LEI status | lapsed |
| LEI first issued | 10 Oct 2024 |
| LEI record last updated | 11 Oct 2025 |
| Next LEI renewal | 10 Oct 2025 |
| Corroboration of the LEI record | partly corroborated |
Group membership
STA PHARMACEUTICAL HONG KONG INVESTMENT LIMITED this entity
Relationship to the parent
| Ultimate parent | |
|---|---|
| Parent | 无锡药明康德新药开发股份有限公司 |
| Accounting period | 1 Jan 2023 to 31 Dec 2023 |
| Evidence | consolidated accounts |
| Corroboration | supplied by the entity only |
| Accounting standard | other standard |
| Relationship start | 7 Oct 2024 |
| Recorded at GLEIF since | 10 Oct 2024 |
| Last updated | 11 Oct 2025 |
| Record status | not renewed |
Parent not reported to GLEIF
- Direct parent: the parent has no LEI and has not consented to obtain one.
Other names
- 合全藥業香港投資有限公司 · trading name